Rapid Micro Biosystems (RPID) Short-term Investments (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Short-term Investments of $9.1 million for Q1 2026, down 59.88% on a YoY basis from $22.8 million in Q1 2025, and down 49.99% sequentially from $18.3 million in Q4 2025.
Rapid Micro Biosystems (RPID) Short-term Investments (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Short-term Investments data on file, last reported at $9.1 million in Q1 2026.
- For the quarter ending Q1 2026, Short-term Investments fell 59.88% year-over-year to $9.1 million; the trailing twelve-month figure through Mar 2026 stood at $9.1 million (down 59.88% YoY), and the FY2025 full-year result was $18.3 million, down 45.99% from the prior year.
- Short-term Investments eased to $9.1 million in Q1 2026, from $18.3 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $99.7 million in Q1 2022 to a low of $9.1 million in Q1 2026.
- A 5-year average of $52.8 million and a median of $57.1 million in 2024 frame the typical range for Short-term Investments.
- Across the five-year window, Short-term Investments soared 7342.51% in 2022 and tumbled 60.14% in 2025, its largest moves.
- Tracing RPID's Short-term Investments over 5 years: stood at $81.6 million in 2022, then declined by 16.93% to $67.8 million in 2023, then plunged by 50.09% to $33.8 million in 2024, then plunged by 45.99% to $18.3 million in 2025, then tumbled by 49.99% to $9.1 million in 2026.
- Business Quant data shows RPID's Short-term Investments at $9.1 million in Q1 2026, $18.3 million in Q4 2025, and $22.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.13 Mn |
| Dec 31, 2025 | 18.27 Mn |
| Sep 30, 2025 | 22.30 Mn |
| Jun 30, 2025 | 12.92 Mn |
| Mar 31, 2025 | 22.76 Mn |
| Dec 31, 2024 | 33.82 Mn |
| Sep 30, 2024 | 38.79 Mn |
| Jun 30, 2024 | 32.27 Mn |
| Mar 31, 2024 | 57.10 Mn |
| Dec 31, 2023 | 67.77 Mn |
| Sep 30, 2023 | 65.60 Mn |
| Jun 30, 2023 | 77.39 Mn |
| Mar 31, 2023 | 75.28 Mn |
| Dec 31, 2022 | 81.58 Mn |
| Sep 30, 2022 | 89.06 Mn |
| Jun 30, 2022 | 94.37 Mn |
| Mar 31, 2022 | 99.73 Mn |
| Dec 31, 2021 | 15.11 Mn |
| Jun 30, 2021 | 1.27 Mn |
| Dec 31, 2020 | 15.00 Mn |